Diffuse Large B-Cell Lymphoma Unclassifiable: Clinical Trials

1 trial for Diffuse Large B-Cell Lymphoma Unclassifiable, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Diffuse Large B-Cell Lymphoma Unclassifiable: new trials by email Literature Review of Diffuse Large B-Cell Lymphoma Unclassifiable trials Research Report on Diffuse Large B-Cell Lymphoma Unclassifiable

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib
Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - Diffuse Large B-Cell Lymphoma Unclassifiable
Phase 2CompletedM.D. Anderson Cancer Center602016-03-292024-03-13

Interventions

CT-P10 (1)  ·  Cyclophosphamide (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Lenalidomide (1)  ·  Prednisone (1)  ·  Rituximab (1)  ·  Vincristine (1)  ·  deltacortene (1)  ·  ibrutinib (1)  ·  prednylidene (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Jason Westin (1)

Results publications

PMID 35952327, PMID 39319495